Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E13.70 EPS (ttm)2.74 Insider Own0.04% Shs Outstand5.55B Perf Week-1.52%
Market Cap206.92B Forward P/E12.15 EPS next Y3.09 Insider Trans-7.66% Shs Float5.52B Perf Month0.29%
Income15.47B PEG- EPS next Q0.67 Inst Own73.00% Short Float0.89% Perf Quarter10.49%
Sales50.66B P/S4.08 EPS this Y62.30% Inst Trans-0.51% Short Ratio1.56 Perf Half Y-0.66%
Book/sh11.72 P/B3.20 EPS next Y7.26% ROA9.60% Target Price41.36 Perf Year-10.63%
Cash/sh1.88 P/C19.99 EPS next 5Y0.00% ROE25.00% 52W Range27.88 - 44.56 Perf YTD-4.31%
Dividend1.52 P/FCF55.31 EPS past 5Y14.70% ROI14.70% 52W High-15.87% Beta0.71
Dividend %4.05% Quick Ratio0.80 Sales past 5Y0.90% Gross Margin80.40% 52W Low34.47% ATR0.85
Employees88300 Current Ratio1.00 Sales Q/Q-8.30% Oper. Margin32.10% RSI (14)55.36 Volatility1.59% 2.23%
OptionableYes Debt/Eq0.80 EPS Q/Q-10.30% Profit Margin31.20% Rel Volume0.69 Prev Close37.49
ShortableYes LT Debt/Eq0.56 EarningsApr 28 BMO Payout51.30% Avg Volume31.41M Price37.49
Recom2.50 SMA20-0.65% SMA506.40% SMA2002.57% Volume0 Change0.00%
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
May-27-20 03:49AM  Pharma exports a rare bright spot for Singapore economy as pandemic drives demand Reuters
May-26-20 02:03PM  Hedge Funds Are Warming Up To Pfizer Inc. (PFE) Insider Monkey
01:47PM  Coronavirus update: Novavax begins vaccine trials; Brazil reports second-highest number of cases in world Yahoo Finance
11:53AM  Novavax expects COVID-19 vaccine trial results in July Yahoo Finance
10:54AM  Anti-anxiety medication prescriptions have spiked 34% during the coronavirus pandemic MarketWatch
10:52AM  The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech, Sanofi and GlaxoSmithKline Zacks
10:13AM  Merck Dives Into Covid-19 Fray With Two Vaccines and One Antiviral Barrons.com
09:59AM  Novavax and Merck Fuel COVID-19 Vaccine Hopes Investopedia
09:39AM  Coronavirus Vaccine Efforts Continue, Novavax Begins Human Trial Zacks
08:00AM  Pfizer Is Charging Ahead With A Coronavirus Vaccine Is PFE Stock A Buy? Investor's Business Daily
08:00AM  AbbVie Wrapped Its $63 Billion Allergan Buyout Is AbbVie Stock A Buy? Investor's Business Daily
07:30AM  ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc. GlobeNewswire
May-24-20 08:21AM  An 'unprecedented' effort to find a coronavirus vaccine has over 100 horses in the race Yahoo Finance
07:33AM  3 Large-Cap Coronavirus Stocks Still Worth Buying Motley Fool
May-23-20 09:15AM  Some wellness products growing over 1,000% during pandemic: Ro CEO Yahoo Finance
May-22-20 04:30PM  Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC Business Wire
04:26PM  Coronavirus latest: Friday, May 22 Yahoo Finance Video
11:50AM  Is Pfizer (PFE) a Great Value Stock Right Now? Zacks
09:22AM  The race for a coronavirus treatment is fanning fears of 'vaccine nationalism' Yahoo Finance Video
07:46AM  Telehealth is going to 'become the default' for patients: Ro CEO Yahoo Finance
07:29AM  Everything you need to know about the Oxford University vaccine and other efforts to beat coronavirus MarketWatch
06:16AM  The race for a coronavirus treatment is fanning fears of 'vaccine nationalism' Yahoo Finance
05:37AM  Pharma Stock Roundup: FDA Ok's Cancer Drugs for New Use, JNJ Stops US Baby Powder Sales Zacks
02:51AM  Coronavirus Vaccine Race Pushes Up Pharma Giants' Production Zacks
May-21-20 03:48PM  Fmr. CDC Official: 'were not cutting any corners' on COVID-19 vaccine development Yahoo Finance Video
10:46AM  For Moderna, a Coronavirus Vaccine Would Be the Tip of the Iceberg Barrons.com
04:22AM  AstraZeneca/Merck's Lynparza Get FDA Nod for Prostate Cancer Zacks
May-20-20 04:50PM  Pfizer Participates in Funding for Biotech Startup Amplyx Motley Fool
04:30PM  FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck Motley Fool
12:00PM  GSK ties up with gene editing start-up Mammoth for COVID-19 test Reuters
11:52AM  Sorrento Therapeutics CEO: We are not a 'pump and dump' scheme Yahoo Finance
08:11AM  Better Buy: GlaxoSmithKline vs. Pfizer Motley Fool
06:42AM  J&J to Stop Sale of Talc-Based Baby Powder in North America Zacks
May-19-20 03:18PM  Johns Hopkins doctor on Trump's preventative hydroxychloroquine use: 'hopefully other people will not follow this example' Yahoo Finance Video
02:59PM  GlaxoSmithKline, Pfizer, and Shionogi's HIV Prevention Candidate Outperforms Gilead's Truvada Motley Fool
11:39AM  Glaxo's Long-Acting HIV Injection Effective Than Daily Pills Zacks
11:39AM  A Covid-19 Vaccine Could Be Worth Billions for Moderna and Its Rivals Barrons.com
08:11AM  Pfizer Seeks To Raise $4 Billion From Debt Sale SmarterAnalyst
06:04AM  What's Behind Axsome Therapeutics' Miracle Pipeline? Motley Fool
05:52AM  Market pros have high hopes for a COVID-19 vaccine: Morning Brief Yahoo Finance
May-18-20 09:24PM  Pfizer Prices $4,000,000,000 Debt Offering Business Wire
02:54PM  We anticipate a U-Shaped to Swoosh-Shaped recovery: Strategist Yahoo Finance Video
02:47PM  Moderna COVID-19 vaccine data is baby-step in right direction: Expert Yahoo Finance Video
02:05PM  Heres what it will take for the stock market to hit a new record within 2 months MarketWatch
12:27PM  Moderna Soars: Biotech ETFs in Focus Zacks
11:52AM  Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; on review for downgrade Moody's
11:38AM  Sarepta Surges on Rival Pfizer's DMD Gene Therapy Study Data Zacks
11:20AM  Who Is Winning the COVID-19 Vaccine Race? Investopedia
10:49AM  Pfizer Reports Efficacy & Safety Data on DMD Gene Therapy Zacks
02:29AM  Glaxo-held firm ends HIV study early as injectable shows higher efficacy than daily pill MarketWatch
May-17-20 02:03PM  Better Buy: Pfizer vs. Bristol Myers Squibb Motley Fool
May-16-20 03:10PM  Economic expert with perfect record calling recessions is betting this one will be over by the end of 2020 MarketWatch
07:21AM  Can Pfizer's Stock Keep Climbing? Motley Fool
May-15-20 04:15PM  Why Sarepta Has A Leg Up On Pfizer With A Rival Gene Therapy: Analysts Investor's Business Daily
03:37PM  Pfizer Posts Positive Data from Duchenne Muscular Dystrophy Candidate, but Still Trails Rival Sarepta Therapeutics Motley Fool
03:09PM  Trump unveils vaccine effort, says country will be back on its feet with or without one Yahoo Finance Video
10:03AM  Sarepta Gains After Pfizer DMD Gene Therapy Data Fall Short Bloomberg
08:01AM  Pfizer to launch late stage DMD gene therapy trial despite hospitalizations Reuters
08:00AM  Pfizers New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study Business Wire
May-14-20 02:01PM  The Zacks Analyst Blog Highlights: LLY, AZN, PFE, SNY and BMY Zacks
11:51AM  Coronavirus Vaccine Progress Accelerates Yahoo Finance
11:33AM  Three Dividend Growth Stocks We Recently Purchased for Our Portfolio GuruFocus.com
11:16AM  Relaxing the Lockdown: Move Slowly, Stay Nimble Yahoo Finance
10:00AM  Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age Business Wire
May-13-20 10:00AM  Save the Date: Pfizer Announces New Date of September 14, 2020 for Rescheduled Investor Day Business Wire
09:34AM  Drug Sector Highly Resilient Amid Coronavirus Mayhem: 5 Picks Zacks
08:16AM  Biotech Companies Lead Search for Coronavirus Vaccine: 4 Winners Zacks
03:43AM  Pfizer Plans To Test Covid-19 Vaccine On Thousands Of Patients By September- Report SmarterAnalyst
02:18AM  Pfizer Plans To Test Coronavirus Vaccine On Thousands Of Patients By September Benzinga
May-12-20 05:07PM  Hedge Fund Tells Alexion Management to Sell Company GuruFocus.com
04:24PM  MEDIA-Pfizer wants to expand human trials of coronavirus vaccine to thousands of people by September - CNBC Reuters
12:00PM  New Data from 18 Approved and Investigational Pfizer Medicines to be Showcased at ASCO20 Virtual Scientific Program Business Wire
10:00AM  Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
07:52AM  Sarepta Investors Buckle Up for Pfizers DMD Gene Therapy Update Bloomberg
May-11-20 05:40PM  US Indexes Post Some Gains Monday GuruFocus.com
04:51PM  Dow ends 100 points lower, leaving stock benchmarks mixed amid skepticism over re-openings MarketWatch
01:12PM  Health-care ETFs rise as coronavirus treatments take center stage MarketWatch
10:53AM  Mylan (MYL) Beats on Q1 Earnings on Coronavirus-Led Stockpiling Zacks
08:50AM  Mylan's stock gains 2%; guidance for 2020 reaffirmed MarketWatch
08:27AM  Mylan first-quarter revenue jumps 5% on drug stockpiling Reuters
May-10-20 09:15AM  Is There A Safer Way to Invest in a Coronavirus Vaccine? Motley Fool
07:33AM  How Low Will Pfizer's Dividend Go After the Mylan-Upjohn Deal? Motley Fool
02:26AM  Pfizer Sets Wheels In Motion For Covid-19 Vaccine Production Ramp SmarterAnalyst
May-09-20 01:23PM  Pfizer Outsources Branded Drug Production to Focus on Experimental Coronavirus Vaccine Motley Fool
May-08-20 06:55PM  Pfizer to outsource some drug production, focus on coronavirus vaccine Reuters
06:40PM  Pfizer to outsource some drug production, focus on coronavirus vaccine Reuters
04:59PM  Stocks jump despite a record 20.5M jobs lost in April Yahoo Finance Video
04:53PM  This PayPal Options Move Is Better Than Cash Barrons.com
02:30PM  ICU Medical Inc (ICUI) Q1 2020 Earnings Call Transcript Motley Fool
11:04AM  Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY Zacks
10:29AM  Nektar's (NKTR) Q1 Earnings and Revenues Top Estimates Zacks
10:00AM  Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting Business Wire
May-07-20 05:45PM  The Dow Rose 211 Points Because Coronavirus Vaccines and Trade Talks Look Possible Barrons.com
05:07PM  Here's Why OPKO Health Shares Tumbled 16.7% Today Motley Fool
04:56PM  Dow ends up 211 points but gains were cut in half headed into the close as Pfizers stock slump weighed MarketWatch
03:11PM  Coronavirus update: US jobless numbers amplify reopening debate; US, NY case split grows Yahoo Finance
02:45PM  Stocks surge despite another grim jobless claims report Yahoo Finance Video
11:15AM  Bristol-Myers' (BMY) Q1 Earnings & Sales Beat Estimates Zacks
09:59AM  Dow Jones Today, Stocks Jump As Jobless Surge Slows: PayPal, Dexcom Lead; Moderna Vaccine Gets FDA Nod Investor's Business Daily
09:59AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Pfizer, Regeneron Pharmaceuticals, Moderna and Sanofi Zacks
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; licensing agreement with Akcea Therapeutics, Inc; strategic alliance with Verily Life Sciences LLC; collaboration agreement with Merck KGaA; clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; material transfer and collaboration agreement with BioNTech SE to co-develop COVID-19 vaccine; clinical supply collaboration Jiangsu Alphamab Biopharmaceuticals Co., Ltd; and collaboration with Valneva SE to develop and commercialize Valneva's Lyme disease vaccine candidate VLA15. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
GOETTLER MICHAELGroup PresidentFeb 28Option Exercise27.3722,852625,45953,036Mar 03 12:54 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3715,996437,81187,956Mar 03 12:54 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3738,8481,063,270172,542Mar 03 12:54 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 28Option Exercise27.3737,9341,038,254140,256Mar 03 12:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 28Option Exercise27.3717,824487,84330,045Mar 03 12:54 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.3791,4082,501,837222,496Mar 03 12:55 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37100,5482,751,999504,427Mar 03 12:55 PM
BOURLA ALBERTChairman & CEOFeb 28Option Exercise27.3733,135906,905232,888Mar 03 12:49 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3727,422750,540140,744Mar 03 12:49 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37173,6754,753,485556,084Mar 03 12:49 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise34.59144,9285,013,060503,738Feb 28 07:32 PM
ROGERS DAWNExecutive Vice PresidentFeb 26Option Exercise34.5915,097522,20524,995Feb 28 07:28 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise34.5972,4642,506,530180,558Feb 28 07:28 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise34.5933,4141,155,79093,211Feb 28 07:24 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise34.5988,5673,063,533189,936Feb 28 07:25 PM
GOETTLER MICHAELGroup PresidentFeb 26Option Exercise34.5920,129696,26245,557Feb 28 07:22 PM
Hwang AngelaGroup PresidentFeb 26Option Exercise34.5914,493501,31332,470Feb 28 07:22 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise34.59144,9285,013,060482,320Feb 28 07:19 PM
BOURLA ALBERTChairman & CEOFeb 26Option Exercise34.5988,5673,063,533274,479Feb 28 07:16 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise34.5924,155835,521131,196Feb 28 07:15 PM
Gottlieb ScottDirectorJan 30Buy37.001,00036,9974,000Jan 31 08:06 AM
PFIZER INC10% OwnerSep 17Buy18.0050,000900,0004,593,847Sep 19 04:19 PM
Gottlieb ScottDirectorAug 23Buy34.723,000104,1603,000Aug 26 09:27 AM
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM